Table 1.
Patient characteristics, structural and functional imaging, and final histopathology
| Case no. | Age (years) | CT |
SUVmax on [18F]FDG-PET/CT | SUVmax on [68Ga]DOTATOC- PET/CT | Ratio of SUVmax of DOTATOC/SUVmax of FDG | HPE | |
|---|---|---|---|---|---|---|---|
| Tumour size (mm) | Tumour site | ||||||
| 1 | 40 | 3.2 × 1.8 | R int. Br | 1.3 | 23.2 | 17.8 | TC |
| 2 | 16 | 1.5 × 0.9 | L main Br | 3.1 | 58 | 18.7 | TC |
| 3 | 35 | 3.8 × 3.7 | R main Br | 3.2 | 43 | 13.4 | TC |
| 4 | 44 | 2.5 × 5 | R LL Br | 1.4 | 11 | 7.8 | TC |
| 5 | 40 | 1 × 0.7 | Posterior basal segment of L LL | 1.0 | 8.8 | 8.8 | TC |
| 6 | 23 | 6.8 × 5 | R hilar area | 2.8 | 33 | 11.7 | TC |
| 7 | 40 | 3.6 × 3.4 | R LL Br | 2.6 | 60 | 23.1 | TC |
| 8 | 45 | 4 × 6 | L main Br | 1.7 | 33 | 19.4 | TC |
| 9 | 25 | 1.8 × 1.5 | R main Br | 0.8 | 20 | 25 | TC |
| 10 | 22 | 3 × 2.5 | R int. Br | 2.7 | 43 | 15.9 | TC |
| 11 | 45 | 3.4 × 4.7 | R int. Br | 1.1 | 33 | 30 | TC |
| 12 | 19 | 3.3 × 2.2 | R int. Br | 2.6 | 45 | 17.3 | TC |
| 13 | 22 | 3.2 × 2.8 | R main Br | 3.0 | 66 | 22 | TC |
| 14 | 53 | 8 × 7 | R main Br | 2.9 | 6.3 | 2.1 | AC |
| 15 | 40 | 5 × 7.1 | R main Br + calcification | 6.4 | 18.5 | 2.8 | AC |
| 16 | 34 | 4 × 4.8 | R LL | 3.1 | 12.3 | 3.9 | AC |
| 17 | 16 | 1.5 × 1.5 | L upper lobe bronchus | 3.9 | 13.9 | 3.6 | AC |
| 18 | 31 | 3.4 × 4.7 | R hilar mass, LL bronchial division | 5.9 | 1.1 | 0.2 | AC |
| 19 | 29 | 5.5 × 1.5 | L main Br | 6.8 | 10.3 | 1.5 | AC |
| 20 | 36 | 4.4 × 3.8 | R main Br | 8.4 | 4.7 | 0.5 | AC |
AC, atypical carcinoid; Br, bronchus; HPE, histopathological examination; Int., intermediate; L, left; LL, lower lobe; PE, pleural effusion; R, right, SUV, standardized uptake value; TC, typical carcinoid.